ATC code M09
| ATC code M: Musculo-skeletal system |
|---|
|
| Other ATC codes |
ATC code M09 Other drugs for disorders of the musculo-skeletal system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M09 is part of the anatomical group M Musculo-skeletal system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM09.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M09A Other drugs for disorders of the musculo-skeletal system
M09AA Quinine and derivatives
- M09AA01 Hydroquinine
- M09AA72 Quinine, combinations with psycholeptics
M09AB Enzymes
- M09AB01 Chymopapain
- M09AB02 Collagenase clostridium histolyticum
- M09AB03 Bromelains
- M09AB52 Trypsin, combinations
M09AX Other drugs for disorders of the musculo-skeletal system
- M09AX01 Hyaluronic acid
- M09AX02 Chondrocytes, autologous
- M09AX03 Ataluren
- M09AX04 Drisapersen
- M09AX05 Aceneuramic acid
- M09AX06 Eteplirsen
- M09AX07 Nusinersen
- QM09AX90 Equine stem cells
- QM09AX99 Combinations
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code M09". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QM09". WHO Collaborating Centre for Drug Statistics Methodology.